A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)
Clinical trial NCT04729907 · COMPLETED
Trial details
- NCT number
- NCT04729907
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2026-07-30
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.